Evidence map›Paper›PMID 35098809›Full record

SynthesisTechnology in cancer research & treatment

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.

Yuwen Jiang, Chenlu Zhang, Ling Lu, Xinfeng Wang, Haiyan Liu, Yijing Jiang, Lemin Hong, Yifan Chen, Hongming Huang, Dan Guo

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuwen Jiang74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Chenlu Zhang74567Department of Hematology, Zhangjiagang Hospital Affiliated to Suzhou University, Suzhou, China.
Ling Lu74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Xinfeng Wang74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Haiyan Liu74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Yijing Jiang74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Lemin Hong74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Yifan Chen74567Nantong University, Nantong, China.
Hongming Huang74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.ORCID 0000-0001-9695-4674
Dan Guo74567Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCyclin D1Gene Expression Regulation, NeoplasticHumansImmunohistochemistryMultiple MyelomaPolymerase Chain ReactionPrognosisPublication BiasSurvival AnalysisBiomarkers, TumorCCND1 protein, humanCyclin D1bortezomibcyclin D1meta-analysismultiple myelomaprognosis

Identifiers

PMID35098809
PMCPMC8811435
OpenAlexW4210793676

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.